Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
systemic clearance | volume of plasma effectively cleared of drug per unit time | The exposure estimate assumes that systemic clearance remained stable over the interval. | Assessment | Drug concentrations, exposure and assay interpretation |
nonrenal clearance | drug elimination through routes other than the kidneys | The review considered a change in nonrenal clearance during the acute illness. | Assessment | Drug concentrations, exposure and assay interpretation |
intrinsic clearance | capacity of an organ's eliminating machinery independent of flow and binding in the model | The report lists intrinsic clearance as a model parameter. | Assessment | Drug concentrations, exposure and assay interpretation |
hepatic extraction ratio | fraction of drug removed from blood during one passage through the liver | The pharmacology note distinguishes the hepatic extraction ratio from total clearance. | Assessment | Drug concentrations, exposure and assay interpretation |
first-pass extraction | presystemic removal before an absorbed dose reaches systemic circulation | The route change prompted review of possible first-pass extraction. | Assessment | Drug concentrations, exposure and assay interpretation |
absolute bioavailability | systemic availability relative to an intravenous reference with dose adjustment | The study estimated absolute bioavailability using paired oral and intravenous data. | Assessment | Drug concentrations, exposure and assay interpretation |
relative bioavailability | systemic availability of one preparation compared with a reference preparation | The formulation comparison reports relative bioavailability. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption lag time | delay between dosing and the start of measurable absorption in a model | The model includes an absorption lag time before concentrations begin to rise. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption rate constant | parameter describing the rate of absorption in a specified model | The fitted absorption rate constant was reported with its units and model assumptions. | Assessment | Drug concentrations, exposure and assay interpretation |
terminal elimination slope | slope of the final log-linear portion of the concentration curve | The terminal elimination slope was estimated from the selected late samples. | Assessment | Drug concentrations, exposure and assay interpretation |
terminal half-life | time for concentration to halve during the terminal log-linear phase | The report gives a terminal half-life based on the final sampling interval. | Assessment | Drug concentrations, exposure and assay interpretation |
distribution half-life | time for the concentration contribution of the distribution phase to decrease by half | The early decline reflects the distribution half-life in the fitted two-compartment model. | Assessment | Drug concentrations, exposure and assay interpretation |
effective half-life | half-life used to describe accumulation or decline for the specified situation | The interpretation specifies how the effective half-life was estimated. | Assessment | Drug concentrations, exposure and assay interpretation |
context-sensitive half-time | time for concentration to fall by half after stopping an infusion of a specified duration | The context-sensitive half-time was interpreted in the context of the prolonged infusion. | Assessment | Drug concentrations, exposure and assay interpretation |
accumulation ratio | measure of exposure after repeated dosing relative to a stated earlier exposure | The reported accumulation ratio compares the same exposure metric across intervals. | Assessment | Drug concentrations, exposure and assay interpretation |
peak-to-trough fluctuation | extent of change between highest and lowest concentrations across a dosing interval | The report defines the calculation used for peak-to-trough fluctuation. | Assessment | Drug concentrations, exposure and assay interpretation |
peak-to-trough ratio | peak concentration divided by trough concentration for the stated interval | The peak-to-trough ratio uses two results from the same dosing interval. | Assessment | Drug concentrations, exposure and assay interpretation |
partial AUC | area under the concentration-time curve over a defined subinterval | The partial AUC was reported for the first four hours with the interval specified. | Assessment | Drug concentrations, exposure and assay interpretation |
AUC to last measurable concentration | exposure integrated through the final quantifiable sample | The report gives AUC to last measurable concentration and identifies the final sample time. | Assessment | Drug concentrations, exposure and assay interpretation |
AUC extrapolated to infinity | total single-dose exposure estimated beyond the last sample using terminal decline | The AUC extrapolated to infinity includes a separately reported extrapolated portion. | Assessment | Drug concentrations, exposure and assay interpretation |
extrapolated AUC fraction | part of the total estimated exposure derived from extrapolation | The extrapolated AUC fraction was reviewed because the late sampling period was short. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized AUC | area under the concentration-time curve divided by the administered dose | The team compared dose-normalized AUC using the same AUC interval in both periods. | Assessment | Drug concentrations, exposure and assay interpretation |
dose-normalized peak | peak concentration divided by the dose used for that observation | The dose-normalized peak was interpreted with the formulation and sampling window. | Assessment | Drug concentrations, exposure and assay interpretation |
average steady-state concentration | average concentration over a dosing interval at steady state | The reported average steady-state concentration was derived from interval exposure and duration. | Assessment | Drug concentrations, exposure and assay interpretation |
time above threshold | duration during which concentration exceeds a specified value | The estimate of time above threshold used the threshold named in the pharmacokinetic report. | Assessment | Drug concentrations, exposure and assay interpretation |